Literature DB >> 7669817

Proteolytic and non-proteolytic activation of human neutrophil progelatinase B.

Q X Sang1, H Birkedal-Hansen, H E Van Wart.   

Abstract

The activation of human neutrophil progelatinase B (pro-HNG) by a variety of proteolytic and non-proteolytic activators has been investigated. A quantitative comparison of the activation efficiencies of treatments previously reported to activate pro-HNG or the related gelatinase B species produced by other cells demonstrates that stromelysin and trypsin are good activators. HgCl2 is a moderately effective activator, while p-chloromercuribenzoate and NaOCl are poor activators. It is also shown that human matrilysin and human fibroblast-type collagenase can activate pro-HNG by a mechanism that is very similar to that of stromelysin. Initially, these proteinases hydrolyze the Glu40-Met41 bond in the propeptide domain to generate an 88 kDa inactive HNG species. Collagenase also generates a 68 kDa HNG species through hydrolysis of the Ala74-Met75 bond. Ultimately, treatment with either matrilysin, collagenase or trypsin results in the production of a 65 kDa active form of HNG that arises from hydrolysis of the Arg87-Phe88 bond. This is the same active species produced on activation by stromelysin. This cleavage site is downstream of the 'cysteine-switch' residue located at position 80 and releases it, accounting for the permanent activation of the enzyme. These results suggest that matrilysin and collagenase may be physiologically relevant activators of pro-HNG and/or other progelatinase B species. Activation by HgCl2 produces an active 68 kDa enzyme due to autolytic hydrolysis of the Ala74-Met75 bond. This species retains the cysteine switch residue; however, it is shown that it is only active in the continued presence of HgCl2. Removal of the HgCl2 restores latency, indicating that this species is reversibly activated by HgCl2, which functions by complexing the sulfhydryl group of the cysteine switch residue and keeping it dissociated from the active site zinc atom. Thus, in spite of reports to the contrary, the cysteine switch mechanism can account for the latency and activation of pro-HNG.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669817     DOI: 10.1016/0167-4838(95)00086-a

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer.

Authors:  Diaa Al-Raawi; Helal Abu-El-Zahab; Mohamed El-Shinawi; Mona Mostafa Mohamed
Journal:  Int J Clin Exp Med       Date:  2011-10-11

2.  Computational sequence analysis of matrix metalloproteinases.

Authors:  Q A Sang; D A Douglas
Journal:  J Protein Chem       Date:  1996-02

3.  Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.

Authors:  G Sehgal; J Hua; E J Bernhard; I Sehgal; T C Thompson; R J Muschel
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development.

Authors:  M A Stolow; D D Bauzon; J Li; T Sedgwick; V C Liang; Q A Sang; Y B Shi
Journal:  Mol Biol Cell       Date:  1996-10       Impact factor: 4.138

5.  Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa).

Authors:  Gargi Maity; Triparna Sen; Amitava Chatterjee
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-28       Impact factor: 4.553

6.  In vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivo.

Authors:  V Rigot; E Marbaix; P Lemoine; P J Courtoy; Y Eeckhout
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

7.  Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin.

Authors:  Q A Sang; M K Bodden; L J Windsor
Journal:  J Protein Chem       Date:  1996-04

8.  Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.

Authors:  Janet C Reid; Admire Matsika; Claire M Davies; Yaowu He; Amy Broomfield; Nigel C Bennett; Viktor Magdolen; Bhuvana Srinivasan; Judith A Clements; John D Hooper
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

9.  Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion.

Authors:  Yunge Zhao; Charles E Lyons; Aizhen Xiao; Dennis J Templeton; Qingxiang Amy Sang; Keith Brew; Isa M Hussaini
Journal:  Biochem Biophys Res Commun       Date:  2008-03-18       Impact factor: 3.575

10.  Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9.

Authors:  Maria Pavlaki; Eleftheria Giannopoulou; Anna Niarakis; Panagiota Ravazoula; Alexios J Aletras
Journal:  Mol Cell Biochem       Date:  2009-03-29       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.